Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Allory

Showing results (41-50 of 229) with videos related to

Pageof 23
Sort By:
Annales De Pathologie|March 2, 2005
[Immunohistochemical characterisation of the main histologic subtypes of epithelial renal tumours on tissue-microarrays. Study of 310 cases]Céline Bazille, Yves Allory, Vincent Molinié, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 16, 2005
[Is tumour grade applicable to finasteride-treated prostate cancer?]Vincent Molinié, Alain Ruffion, Yves Allory, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapyClarice S Groeneveld, Jacqueline Fontugne, Luc Cabel, et al.
Virchows Archiv : an International Journal of Pathology|October 19, 2005
Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literatureSophie Ferlicot, Yves Allory, Eva Compérat, et al.
Urologic Oncology|August 25, 2021
Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UCMyriam Kossaï, Camélia Radulescu, Julien Adam, et al.
Nature|May 17, 2019
Progenitors from the central nervous system drive neurogenesis in cancerPhilippe Mauffrey, Nicolas Tchitchek, Vilma Barroca, et al.
Urologia Internationalis|January 9, 2013
Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocolNathalie Nicolaiew, Guillaume Ploussard, Felix K-H Chun, et al.
Nature|January 9, 2020
Publisher Correction: Progenitors from the central nervous system drive neurogenesis in cancerPhilippe Mauffrey, Nicolas Tchitchek, Vilma Barroca, et al.
BJU International|June 26, 2010
Prospective evaluation of combined oncological and functional outcomes after laparoscopic radical prostatectomy: trifecta rate of achieving continence, potency and cancer control at 2 yearsGuillaume Ploussard, Alexandre de la Taille, Evanguelos Xylinas, et al.
Urologic Oncology|February 4, 2012
Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillanceGuillaume Ploussard, Alexandre de la Taille, Stéphane Terry, et al.
Pageof 23

Showing results (41-50 of 229) with videos related to

Sort By:
Pageof 23
Annales De Pathologie|March 2, 2005
[Immunohistochemical characterisation of the main histologic subtypes of epithelial renal tumours on tissue-microarrays. Study of 310 cases]Céline Bazille, Yves Allory, Vincent Molinié, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 16, 2005
[Is tumour grade applicable to finasteride-treated prostate cancer?]Vincent Molinié, Alain Ruffion, Yves Allory, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapyClarice S Groeneveld, Jacqueline Fontugne, Luc Cabel, et al.
Virchows Archiv : an International Journal of Pathology|October 19, 2005
Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literatureSophie Ferlicot, Yves Allory, Eva Compérat, et al.
Urologic Oncology|August 25, 2021
Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UCMyriam Kossaï, Camélia Radulescu, Julien Adam, et al.
Nature|May 17, 2019
Progenitors from the central nervous system drive neurogenesis in cancerPhilippe Mauffrey, Nicolas Tchitchek, Vilma Barroca, et al.
Urologia Internationalis|January 9, 2013
Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocolNathalie Nicolaiew, Guillaume Ploussard, Felix K-H Chun, et al.
Nature|January 9, 2020
Publisher Correction: Progenitors from the central nervous system drive neurogenesis in cancerPhilippe Mauffrey, Nicolas Tchitchek, Vilma Barroca, et al.
BJU International|June 26, 2010
Prospective evaluation of combined oncological and functional outcomes after laparoscopic radical prostatectomy: trifecta rate of achieving continence, potency and cancer control at 2 yearsGuillaume Ploussard, Alexandre de la Taille, Evanguelos Xylinas, et al.
Urologic Oncology|February 4, 2012
Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillanceGuillaume Ploussard, Alexandre de la Taille, Stéphane Terry, et al.
Pageof 23